Beijing Tong Ren Tang Herbal Cough Medicine Recalled in Australia

The Australian branch of a Chinese herbal medicine company in has issued an urgent recall of two batches of its cough medicine after the Therapeutic Goods Administration found contaminants linked to cancer in its products in December 2018. Photo from Bronchi-cough Pills (qiguanyan kesou tanchuanwan)- Recall due to contamination, 2018, Therapeutic Goods Administration, used with permission of the Australian Government https://www.tga.gov.au/alert/bronchi-cough-pills-qiguanyan-kesou-tanchuanwan

The Australian branch of a China-based herbal medicine company has issued an urgent recall for two batches of its herbal cough medicine after the Therapeutic Goods Administration (TGA) found contaminants linked to cancer in its product.

Beijing Tong Ren Tang Australia said it is recalling batch 16080020 and batch 4080015 of its bronchi-cough pills (Qiguanyan Kesou Tanchuanwan) because traces of aristolochic acid and amygdalin were found in one batch, and amygdalin found in the other.